World Glucose Self-Testing Markets 2016 - Undergoing a Significant Transition Driven by New Recommendations for Tight Glucose Control for Monitoring Diabetes

Dublin, Jan. 13, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/zgl8cn/world_glucose) has announced the addition of the "World Glucose Self-Testing Markets" report to their offering.

The worldwide incidence of diabetes is dramatically increasing, and it is estimated that 439 million people will have developed the disease by 2030. As such, the global market for blood glucose self-testing products is undergoing a significant transition driven by the advent of new analytical technologies and new recommendations for tight glucose control for monitoring diabetes. In addition, the proliferation of the middle class within developing nations, particularly China and India, has resulted in both a substantial rise in Type 2 diabetes and the financial means to manage the disease.

The purpose of this report is to provide a comprehensive analysis of the specific segment of the over-the-counter diagnostics sector known as the glucose self-testing market. The term "self-testing" is used to distinguish it from in vitro diagnostics testing for blood glucose in hospitals, commercial labs and doctor's offices, the so-called "professional" component of the glucose testing market.

This study reviews the viable technology drivers and assesses the market dynamics of the glucose self-testing market worldwide. This report also looks at the industry challenges and potential threats, and it makes strategic recommendations for boosting market share.

Key Topics Covered:

1. Overview

2. Diabetes

3. Market Analysis: Size, Growth, Share and Competitors

4. Glucose Diagnostic and Monitoring Recommendations

5. Glucose Self-Testing Technology Platforms and Consumable Products

6. Glucose Self-Testing Meters on the Market: Description of Test Meters

7. Business Trends in the Industry

8. Technology Trends

9. OTC Testing: Critical Issues

10. Current Issues for OTC and Diagnostic Self-Testing

11. SWOT Analysis

12. Company Profiles

Companies Mentioned

• 77 Elektronika Kft.
• A. Menarini Diagnostics
• ACON Laboratories
• ARKRAY USA, Inc.
• Abbott Laboratories
• AgaMatrix
• Allmedicus Co., Ltd.
• Apex Biotechnology Corporation
• B. Braun Melsungen
• Bayer
• Bionime
• Cambridge Sensors
• Cardiocom
• DexCom
• Diagnostic Devices/Prodigy Diabetes Care
• Echo Therapeutics, Inc.
• Entra Health Systems
• FIFTY50 Medical, Inc.
• Fora Care
• Genesis Health Technologies
• GlucoPlus
• GlySens, Inc.
• Google
• Hainice Medical
• Home Diagnostics
• IN4 Technology
• Infopia
• Integrity Applications
• Johnson & Johnson
• LabStyle Innovations Corporation
• Livongo Health
• Medtronic
• Miraculins
• Nipro Corporation
  

For more information visit http://www.researchandmarkets.com/research/zgl8cn/world_glucose

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716

         Sector: Home Testing and Home Healthcare, Glucose Testing